Hims says Novo lawsuit over Wegovy patent "is a blatant attack"
Source: SeekingAlpha
2026-02-09 09:22:02 ET
More on Hims & Hers Health, Novo Nordisk
- Hims & Hers: Decelerating Growth And Cowboy Management, Material Downside Risk
- Hims & Hers: GLP-1 Revenues Can't Be Relied On
- Novo Nordisk: There's Plenty Of Value In Avoiding This Stock
- Novo soars, Hims & Hers sinks, following compounded drug drama
- Biggest stock movers Monday: SOFI, HIMS, and more
Read the full article on Seeking Alpha
For further details see:
Hims says Novo lawsuit over Wegovy patent “is a blatant attack”
WW International Inc.
NASDAQ: WW
WW Trading
-5.12% G/L:
$21.69 Last:
72,785 Volume:
$22.08 Open:
WW Latest News
February 27, 2026 04:01:00 pm
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
February 10, 2026 09:00:00 am
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
WW Stock Data
$241,583,788
9,876,073
0.39%
42
N/A
Personal Services
Consumer Discretionary
US
New York
